The QR 678 ® was invented by a team lead by Dr. Debraj Shome, a renowned Facial Plastic Surgeon and Dr. Rinky Kapoor, a well-known dermatologist. Dr. Shome & Dr. Kapoor co-founded The Esthetic Clinics®, which are a chain of top class dermatology & plastic surgery centers located in various cities in India.
The QR 678 ®is a proprietary, first in class hair fall & hair regrowth therapy, which has revolutionized the treatment of hair fall in alopecia. This formulation has been named QR678 inspired by the new generation ubiquitous presence of “Quick Response“ QR code. 678 in Morse Code signifies “there is no answer”. This formulation has been named QR678™ to signify a “Quick Response to a disease which earlier had no answer”.
Clinical research conducted on this was published:
Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth – safety and efficacy evaluation in a first-in-man pilot clinical study. Kapoor R, Shome D. J Cosmet Laser Ther. 2018 Feb 26:1-11. doi: 10.1080/14764172.2018.1439965.
The same has now secured FDA permissions for manufacturing for commercial sales, within India.
This research is revolutionary in the sense that not only a novel medicine to treat hair fall has been invented by a clinician researcher based in India, this has garnered international recognition by way of a US patent and now commercialization is being performed!
These works on inventing new drugs for cancer, using nano-technology, are ongoing and significant progress is still being made by Dr. Debraj Shome and the team.
In addition, Dr. Shome’s landmark papers have significantly altered practice patterns globally, in facial plastic surgery & facial aesthetics
Dr. Debraj Shome’s most significant work has been to form & lead multi-specialty teams, involving basic & clinical scientists from the Indian Institute of Technology (IIT) Mumbai, India & clinicians from the top hospitals, to formulate new revolutionary drugs for hair growth, cancer therapy & for facial plastic surgery. This task is a much more difficult task in India, since India does not really have large universities which can provide this sort of environment for multi-specialty research, so this task of formulating new drug molecules, stabilizing them, performing animal trials and ultimately using them in human clinical trials, leading to successful treatments of diseases, needs to be recognized and lauded.